Obesity-Related Inflammation and Covid-19 Prognosis: Is the White Adipose the Villain?*Corresponding Author:
Copyright: © 0 . This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
The emergence novel coronavirus (SARS-CoV-2/COVID-19) has become a worldwide pandemic health threat, causing severe respiratory syndrome in humans. COVID-19 effects, which were first observed in the respiratory tract, are continuously being found and characterized in different organs, and the disease now considered systemic. Recent studies show COVID-19 to have repercussions in the heart, central nervous system, liver, and kidney. Also, it is becoming increasingly clear that the presence of comorbidities is associated with COVID-19 severity and lethality. Thus, the highest fatality rates in infected patients with COVID-19 are related to the presence of diabetes mellitus, cardiovascular diseases (CVD), cancer, and chronic respiratory disease. An unbalanced immune reaction underlines the release of inflammatory cytokines, such as IL-6, IL-1β, IFNγ, inducing the “cytokine storm” in infected patients